FDA Carves Out Broad Powers In Drug Inspections

By Jeff Overley (July 22, 2013, 5:25 PM EDT) -- The U.S. Food and Drug Administration is asserting broad investigative powers in new guidance describing how it polices drugmakers, claiming wide authority to seize shoddy products if a manufacturer tries to impede inspectors and making its boldest declaration yet that inspectors can snap photographs that are critical to proving cases, lawyers say....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!